// App-Quantinova.ai

8540 : Ikaros expression levels to predict response and survival following pomalidomide and dexamethasone in multiple myeloma (MM).

Researchers

Presenter

  • Yuan Xiao Zhu

Principal Investigators

  • Esteban Braggio

  • Chang-Xin Shi

  • Kristina M Laumann

  • Rafael Fonseca

  • P. Leif Bergsagel

  • Joseph Mikhael

  • Martha Lacy

  • Mia D. Champion

  • Jessica E Schmidt

  • Xiu-bao Chang

  • Paul Langlais

  • Luo Moulun

  • Patrick Jedlowski

  • Betsy LaPlant

  • A. Keith Stewart

  • K. Martin Kortm

  • Laura A Bruins

Medical Centers

  • ASU, Scottsdale, AZ

  • Mayo Clinic, Rochester, MNMayo Clinic, Scottsdale, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved